Real-world evidence data (RWED) of Financial Toxicity in Patients Receiving Cancer Immunotherapy Treatments
Researched by Belong.Life and published by ASCO 2020 Authors: D A Vorobiof, L Hasid, I Deutsch, A Litvin, E Malki Abstract: RWED of financial toxicity was reported by the majority of cancer pts receiving Immunotherapy drugs for treatment of their solid tumors. 48% of the pts were aware of possible FTs as a result of […]
Using a digital patient powered research network to identify outcomes of importance to patients with multiple myeloma
Authors: Katharine S. Gries & John Fastenau Background: Social media platforms give patients a voice by allowing them to discuss their health and connect with others. These unfiltered and genuine reports offer direct access to what matters most to patients. Exploring the patient-reported outcomes discussed in these platforms reveal clinical insights and behavioral patterns of […]
Evaluating the dyadic management of sexuality-related parameters in women with early breast cancer (EBC): The emergence of “partner reported outcome measurements” (pROMs)
Researched by Belong.Life and published by ASCO Authors: Eli Sapir, Benjamin W. Corn, Lior Hasid, Irad Deutsch, Daniel A. Vorobiof Background:Patient-centered healthcare has focused on incorporating the values of patients (Pts) during clinical decision-making. Accordingly, assessments are often executed with patient reported outcome measurements (PROMs). In the context of tumors located in a sexual organ, […]
Clinical trials participation is directly influenced by the information received by cancer patients (pts) and caregivers: Real-world evidence with the use of a specialized digital health platform.
Researched by Belong.Life and published by ASCO Authors: Keren Greenfeld-Barsky, Lior Hasid, Daniel A. Vorobiof, Eliran Malki Background:Clinical trials (CT) participation is both crucial for medical advancement and an important treatment option, at times the only one, for oncological pts. However, only an estimate of ~3% of cancer pts worldwide enrolls into such trials. Different […]
Covid 19 vaccines in cancer patients (pts), real-world data (RWD) from 1069 Belong.life users
Authors: Eli Sapir, Noy Moisa, Alon Litvin, Eliran Malki, Daniel Vorobiof, Assuta Ashdod Hospital Background: The COVID-19 pandemic continues to have a serious impact on cancer pts management. At the end of December 2020, the US CDC and oncology groups (ASCO, ESMO, ACS) made general vaccine recommendations for cancer pts. Methods: HODS 1069 patients, users […]
